Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› MDS
Clinical trial register · China

MDS Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 09 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Suzhou 3 Shanghai 3 Beijing 2 Changsha 1 Chongqing 1
Narrow the registerReset
Recruitment status
Phase
Site location
Suzhou3 Shanghai3 Beijing2 Changsha1 Chongqing1
All 12 locations
Target enrolment
to

MDS trials in China

10 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
NCT07575412Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell
The First Affiliated Hospital of Soochow University
Phase 2
180
Suzhou
2026-06
Not yet open
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
NCT07562568Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell
The First Affiliated Hospital of Soochow University
Phase 2
160
Suzhou
2026-06
Not yet open
Ruijin Hospital
Phase 2
45
Shanghai
2025-08-01
Recruiting
Ruijin Hospital
Phase 2/3
126
Shanghai
2025-06-10
Recruiting
Peking University First Hospital
Phase 2/3
24
Beijing
2025-05-03
Recruiting
Cullgen (Shanghai),Inc
Phase 1
45
Nanchang, Tianjin, Wuhan
2025-04-17
Not yet open
Ruijin Hospital
Phase 2
73
Shanghai
2025-01-01
Recruiting
Peking University People's Hospital
Observational
300
Beijing
2024-01-08
Active, closed
First Affiliated Hospital of Zhejiang University
Phase 3
232
Changsha, Chongqing, Hangzhou, Nanjing, Ningbo, Suzhou
2020-09-01
Active, closed
Guangdong Provincial People's Hospital
Observational
224
Guangzhou
2020-01-01
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/condition/mds

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 09 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition MDS.

How many MDS trials are recruiting in China?

4 of the 10 studies on this page are recruiting new participants as of the 09 Nov 2026, 03:17 UTC sync. A further 4 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (MDS), 10 studies
PhaseStudiesRecruitingShare
Phase 24040%
Observational2120%
Phase 2/32220%
Phase 11110%
Phase 31010%

Most active sponsors

Lead sponsors with the most studies (MDS)
Lead sponsorStudiesRecruiting
Ruijin Hospital31
The First Affiliated Hospital of Soochow University20
Cullgen (Shanghai),Inc11
First Affiliated Hospital of Zhejiang University10
Guangdong Provincial People's Hospital10
Peking University First Hospital11
Peking University People's Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.